Claire Diane Slinger

Mrs. Claire Diane Slinger

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in International Journal of Language & Communication Disorders
Verified
Journal Article
Closed access
PDF file
JAJodi Allen
Jodi Allen
GCGemma Clunie
Gemma Clunie
CSClaire Diane Slinger
Claire Diane Slinger
JHJemma Haines
Jemma Haines
CMCorinne Mossey‐Gaston
Corinne Mossey‐Gaston
RGRoganie Govender
Roganie Govender

23 July 2019 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
SMSyed B Mehdi
Syed B Mehdi
SMStephen J Milan
Stephen J Milan
SDSteven Dodd
Steven Dodd
JMJessica Matthews
Jessica Matthews
PMPaul A Marsden
Paul A Marsden

8 February 2019 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
RSRichard Slinger
Richard Slinger
AVAashish Vyas
Aashish Vyas
JHJemma Haines
Jemma Haines
SFStephen J. Fowler
Stephen J. Fowler
Objectives: To perform a systematic literature review on the use of Heliox with patients with inducible laryngeal obstruction/vocal cord dysfunction to: i) identify current evidence base; and ii) establish the methodological quality of published research.Methods: Articles published up to March 2018 were searched for key words and terms using Cochrane Library, MEDLINE, PubMed, CINAHL, EMBASE and Dynamed. Studies were included if they presented original research into the use of Heliox for vocal cord dysfunction.Results: Only three studies met the inclusion criteria for review. All reported favorable results for the use of Heliox as an adjunctive therapy for vocal cord dysfunction but none had sufficient methodological quality to support their conclusions.Conclusion: Despite review articles recommending the use of Heliox in vocal cord dysfunction, there is a lack of good quality research to support this conclusion. There is a need for further research to investigate the effectiveness of Heliox as an adjunctive therapy for vocal cord dysfunction.Level of Evidence: 4

17 January 2024 in Advances in Communication and Swallowing
Verified
Journal Article
Closed access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
PLPaul Leong
Paul Leong
SSSally Spencer
Sally Spencer
RSRichard Slinger
Richard Slinger
RGRoganie Govender
Roganie Govender
BACKGROUND: Inducible laryngeal obstruction (ILO) describes an inappropriate narrowing of the larynx during breathing in. ILO can lead to several respiratory symptoms and be misidentified and treated as asthma, with associated patient morbidity and healthcare cost. ILO is also known as vocal cord dysfunction, or paradoxical vocal fold movement. The current reference assessment tool for diagnosing ILO is a video-laryngoscopy. However, timely access to specialist diagnostic laryngoscopy services may be challenging, and laryngoscopy may be poorly tolerated. AIMS: The aim of this cross-sectional, two-stage feasibility study is to determine whether abnormal vocal fold movements associated with ILO can be adequately visualised using trans-laryngeal ultrasound (TLUS) namely, the ILOTUS study: (ILO assessment via trans- laryngeal ultrasound). The second aim is to compare TLUS with a reference standard diagnostic tool to ascertain whether it may serve as a less invasive screening tool to assess ILO. Participants’ opinions about the acceptability of TLUS will also be gathered and compared with responses to a validated symptom score questionnaire. METHODS: In stage one, healthy volunteers (n = 30) will undergo TLUS to assess whether the vocal folds can be visualised,and whether narrowing of the vocal folds can be seen when they mimic ILO. Stage 2 will be conducted with a patient population(n = 30) referred to a tertiary airways service for breathlessness assessment. Participants in stage 2 will undergo the reference standard laryngoscopy as well as simultaneous TLUS. The level of agreement between TLUS and laryngoscopy will be evaluated, as well as comparison of symptom scores. DISCUSSION: This study will help inform future studies of the utility of TLUS in the assessment of ILO. This will be valuable for understanding whether TLUS could be offered as a non-invasive option for patients in the assessment of ILO if they are not able to tolerate or access laryngoscopy diagnostic services. It is not intended that TLUS will replace the current reference standard of video-laryngoscopy but may have potential as an early screening tool if found to be non-inferior.

16 November 2018 in Thorax
Verified
Conference Paper
Closed access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
AVA Vyas
A Vyas
RSRj Slinger
Rj Slinger
JBJ Blakemore
J Blakemore
Introduction Inducible laryngeal obstruction (Ilo) is defined as an inappropriate adduction of the larynx on inspiration. Speech and language therapy (SLT) is viewed as the cornerstone of treatment of Ilo. Clinical consensus indicates that the optimal number of SLT sessions is between four and six. Our previous research has shown that% Forced Vital Capacity (% FVC) is a reliable predictor of Ilo in patients with breathlessness referred to our tertiary airways service (ERS Congress, 2017). In our current research, we aimed to investigate whether% FVC and other patient factors can predict improvement in Ilo symptoms following SLT intervention. Methods Data were analysed from 59 patients presenting to our service with symptoms of breathlessness. All had a diagnosis of Ilo via videolaryngoscopy and received SLT treatment. Analyses investigated relationships between improvement on Ilo symptoms and% FVC as well as other patient details. The VCDQ, a validated questionnaire measuring Ilo symptoms and response to SLT, was used pre- and post-therapy to assess improvement. Results VCDQ scores decreased following SLT for forty (68%) patients, demonstrating improvement. Of patients who improved, the mean number of SLT sessions was four, with the majority (60%) attending three to five sessions. No relationships were found between post-SLT improvement on the VCDQ and patient factors including age, gender, and potential co-morbidities such as asthma, GORD and rhinitis. There was a significant relationship between% FVC and VCDQ improvement (r=0.346, n=51, p=0.01). A binary logistic regression assessed the impact of% FVC on VCDQ improvement. The model was significant (χ 2=6.337 (1, n=59) p=0.012), and explained between 12% and 16% of the variance in improvement, correctly classifying 69% of cases. Patients with higher% FVC were five times more likely to show improvement on the VCDQ following SLT. Conclusions In line with clinical consensus, 3 to 5 sessions of SLT were sufficient to lead to improvements on VCDQ scores for the majority of patients. Patient demographic data did not predict improvements in Ilo following SLT, however% FVC may be a predictor of good treatment response to SLT for Ilo.

4 July 2018 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
CSClaire Diane Slinger
Claire Diane Slinger
SMSyed B Mehdi
Syed B Mehdi
SMStephen J Milan
Stephen J Milan
SDSteven Dodd
Steven Dodd
JBJessica Blakemore
Jessica Blakemore
PMPaul A Marsden
Paul A Marsden